The concentration of 6-keto-PGF1α and TXB2 in plasma samples from patients with benign and malignant tumours of the breast
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 29 (4) , 513-528
- https://doi.org/10.1016/0090-6980(85)90076-0
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasisBiochemical Pharmacology, 1983
- Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1981
- Prostacyclin: A Potent Antimetastatic AgentScience, 1981
- Prostacyclin metabolites in human plasmaClinical Pharmacology & Therapeutics, 1981
- Prostaglandin E and hypercalcemia in breast carcinoma: Only a tumor marker?The American Journal of Medicine, 1979
- The effects of indomethacin on arachidonic acid and prostaglandins e2 and f2alpha levels in human skin 24 h after u.v.B and u.v.C irradiation.British Journal of Clinical Pharmacology, 1978
- 15-KETO-13, 14-DIHYDROPROSTAGLANDIN E2 CONCENTRATIONS IN SERUM OF PATIENTS WITH BREAST CANCERThe Lancet, 1977
- Endogenous formation of the prostaglandin endoperoxine metabolite, thromboxane B2, by brain tissueBiochemical and Biophysical Research Communications, 1976
- BREAST CANCER, PROSTAGLANDINS, AND BONE METASTASESThe Lancet, 1975
- Prostaglandin endoperoxides VII. Novel transformations of arachidonic acid in guinea pig lungBiochemical and Biophysical Research Communications, 1974